You can try out Gemini, Google’s rival to ChatGPT, for free. It’s super easy to access right inside Bard.
Category: Business
Google Just Launched Gemini, Its Long-Awaited Answer to ChatGPT
Google says Gemini, launching today inside the Bard chatbot, is its “most capable” AI model ever. It was trained on video, images, and audio as well as text.
How to Stop Another OpenAI Meltdown
OpenAI designed its governance structure to protect humanity—and it imploded. The company could take pointers from Mozilla and other projects combining lofty goals with for-profit ventures.
The Pilots Delivering Your Amazon Packages Are Ready to Strike
Pilots for Amazon’s largest air freight provider voted to strike, complaining of low pay and high turnover. If a strike happens in the new year, Amazon deliveries could be impacted.
Spotify Is Screwed
Spotify is the world’s biggest music streamer but rarely turns a profit and just cut 17 percent of its workforce. Its business model looks increasingly precarious.
The Rise of AI in Alternative Browsers—and What’s Next
Developers at smaller companies have been adding new ways to experience the internet with AI assistance. Their visions for the future radically differ.
OpenAI Committed to Buying $51 Million of AI Chips From a Startup Backed by CEO Sam Altman
Documents show that OpenAI signed a letter of intent to spend $51 million on brain-inspired chips developed by startup Rain. OpenAI CEO Sam Altman previously made a personal investment in Rain.
Anduril’s New Drone Killer Is Locked on to AI-Powered Warfare
Autonomous drones are rapidly changing combat. Anduril’s new one aims to gain an edge with jet power and AI.
These Clues Hint at the True Nature of OpenAI’s Shadowy Q* Project
Reports of a mysterious breakthrough called Q* at OpenAI sparked anxious rumors. AI experts say it’s probably just a conventional attempt to make ChatGPT a little smarter.
Sam Altman Officially Returns to OpenAI—With a New Board Seat for Microsoft
The CEO’s memo to staff announces a nonvoting seat for Microsoft but leaves questions about the future of chief scientist Ilya Sutskever.